Silence Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Hello, and once again, I'd like to welcome you to the 19th Annual Morgan Stanley Healthcare Conference. My name is David Lebowitz. I'm one of the biotechnology analysts here. Before we get going, I'm going to read the requisite disclosures. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'll begin. I'm happy to have in the next session with us an RNAi company named Silence Therapeutics. From the company, we have President and CEO, Mark Rothera; CFO, Craig Tooman; and Executive Vice President, Head of R&D and Chief Medical Officer, Dr. Giles Campion.
Questions & Answers
And with that, I guess, if you could start off by running us through what
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |